SCHEMBL23933946

SCHEMBL23933946

O=C(CCC(=O)OCC1COC(=O)O1)OCC(O)COCCCCCCOCC(O)COC(=O)CCC(=O)OCC1COC(=O)O1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
PPM1A P35813 1/20 0.35
KDM4E B2RXH2 1/20 0.34
DUSP3 P51452 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HSPD1 P10809 1/20 0.34
HSPE1 P61604 1/20 0.34
TST Q16762 1/20 0.34
MGLL Q99685 1/20 0.34
MAPT P10636 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LPAR6 P43657 1/20 0.33
LPAR1 Q92633 1/20 0.33
LPAR4 Q99677 1/20 0.33
LPAR5 Q9H1C0 1/20 0.33
LPAR2 Q9HBW0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23895372 0.84 LMNA (0.43) LMNAPOLBKDM4EDUSP3MEN1
SCHEMBL17227788 0.81 MGLL (0.46) LMNAPOLBMGLLLPAR1LPAR3
SCHEMBL21301194 0.81 LMNA (0.44) LMNAPOLBMGLL
SCHEMBL14003899 0.79 LMNA (0.46) LMNAPOLBMGLLLPAR1LPAR3
SCHEMBL13217160 0.79 LMNA (0.50) LMNAPOLBMGLLLPAR1
SCHEMBL22490185 0.77 ALDH1A1 (0.39) LMNAMEN1KMT2AMAPT
SCHEMBL15427608 0.77 ALDH1A1 (0.43) LMNAMEN1KMT2AMAPT
SCHEMBL13599890 0.76 ALDH1A1 (0.51) LMNAPOLBMGLLLPAR1
SCHEMBL17830438 0.75 LPAR1 (0.52) LPAR1LPAR3ENPP2
SCHEMBL12920227 0.75 LPAR1 (0.52) LPAR1LPAR3ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210324141-A1 METHOD FOR PRODUCING NON-ISOCYANATE POLYURETHANES HENKEL AG & CO. KGAA (DE) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210324141-A1 METHOD FOR PRODUCING NON-ISOCYANATE POLYURETHANES UROD, IDH3A, SQLE LMNA 2701/4885POLB 1386/4885PPM1A 4812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.